Luke Timmerman (Xconomy)
Paving the Way for Personalized Medicine: FDA’s Role in a New Era of Medical Product Development (FDA)
F.D.A. Shift on Painkillers Was Years in the Making
Barry Meier and Eric Lipton (New York Times)
You may know a drug cocktail is dangerous before FDA
Chris Morris (special to CNBC)
Red (and Green) Flags To Look for With Biotech’s Buyside Investors
Katrine Bosley (guest to Xconomy)
The latest in a string of posts on the "red flags" topic, this time from the view of the corner office. Click here for a round-up of all the recent articles.
Pump&Dump.con: Tips for Avoiding Stock Scams on the Internet
Securities and Exchange Commission (SEC)
The Real Reason Craig Venter May Deserve A Nobel Prize
Matthew Herper (Forbes)